The Weekly Litigation News Digest is now live. Subscribe now

Cl Biosciences competitive analysis

Loading summary...

Explore Cl Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Feb 17, 2021Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of Osteoporosis1

Latest PTAB cases involving Cl Biosciences

Discover the latest PTAB cases involving Cl Biosciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cl Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CL BIOSCIENCES - 1 - -
TRIO MEDICINES1 - - -